Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Polycystic Ovary Syndrome 3 Peripheral Nervous System Diseases 2 Neoplasms 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Pancreatic Neoplasms 1 Overweight 1 Osteosarcoma 1 Obesity 1 Neuroblastoma 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Motor Activity 1 Mesothelioma 1 Meningioma 1 Medulloblastoma 1

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × Tablets × 1 year × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡